RVBD » Topics » Directors Compensation

This excerpt taken from the RVBD DEF 14A filed Apr 24, 2009.

Directors Compensation

The following table sets forth all of the compensation awarded to, earned by, or paid to our non-employee directors in fiscal year 2008.

 

Name

   Fees Earned or
Paid in Cash
($)
   Option Awards
($) (1)
    Total
($)

Mark Floyd

   40,000    397,643 (2)   437,643

Michael R. Kourey

   50,000    251,256 (3)   301,256

Stanley J. Meresman

   45,000    242,130 (4)   287,130

Christopher J. Schaepe

   40,000    121,372 (5)   161,372

James R. Swartz

   40,000    121,372 (6)   161,372

 

(1) The amounts in this column represent the dollar amount recognized for financial statement reporting purposes with respect to the 2008 fiscal year in accordance with Statement of Financial Accounting Standard No. 123 (revised 2004), Share-Based Payment, or SFAS 123(R). See Note 1 of the notes to our consolidated financial statements contained in our Annual Report on Form 10-K filed on February 23, 2009 for a discussion of all assumptions made by the Company in determining the grant date fair value of its equity awards.

 

12


Table of Contents
(2) On May 29, 2008, Mr. Floyd was granted an option to purchase 28,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $211,364. On August 14, 2007, Mr. Floyd was also granted an option to purchase 70,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $1,462,573. As of December 31, 2008, Mr. Floyd held outstanding options to purchase an aggregate of 98,000 shares of our common stock.

 

(3) On May 29, 2008, Mr. Kourey was granted an option to purchase 28,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $211,364. On November 6, 2007, Mr. Kourey was also granted an option to purchase 28,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $553,552. On March 28, 2006, Mr. Kourey was also granted an option to purchase 60,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $275,490. On April 12, 2006, Mr. Kourey was also granted an option to purchase 10,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $49,185. As of December 31, 2008, Mr. Kourey held outstanding options to purchase an aggregate of 105,000 shares of our common stock.

 

(4) On May 29, 2008, Mr. Meresman was granted an option to purchase 32,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $241,558. On November 6, 2007, Mr. Meresman was also granted an option to purchase 32,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $632,630. On September 1, 2006, Mr. Meresman was also granted an option to purchase 32,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $191,347. As of December 31, 2008, Mr. Meresman held outstanding options to purchase an aggregate of 96,000 shares of our common stock.

 

(5) On May 29, 2008, Mr. Schaepe was granted an option to purchase 20,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $150,974. On November 6, 2007, Mr. Schaepe was also granted an option to purchase 20,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $395,394. As of December 31, 2008, Mr. Schaepe held outstanding options to purchase an aggregate of 40,000 shares of our common stock.

 

(6) On May 29, 2008, Mr. Swartz was granted an option to purchase 20,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $150,974. On November 6, 2007, Mr. Swartz was also granted an option to purchase 20,000 shares of our common stock. The grant date fair value of such option, computed in accordance with SFAS 123(R), was $395,394. As of December 31, 2008, Mr.  Swartz held outstanding options to purchase an aggregate of 40,000 shares of our common stock.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki